CAS 1363687-32-4

Dinutuximab

CAS: 1363687-32-4

Dinutuximab is a recombinant chimeric monoclonal antibody targeting GD2, with potential anti-cancer activity, used in high-risk neuroblastoma research.

Reinheit: >95%

Farbe und Form: Liquid

Molekulargewicht: 144.86 kDa

Ref: TM-T77447

Dinutuximab

CAS: 1363687-32-4

Dinutuximab

Reinheit: ≥95%

Ref: 54-BUP20092

Dinutuximab

CAS: 1363687-32-4

Anti-GD2 monoclonal antibody

Reinheit: Min. 95%

Ref: 3D-BD164046